release form and the active substances medications "Makmiror»
This drug is a lenticular white pills, sugar-coated.
«Makmiror" sold in cardboard packs with two blisters of 10 tablets each.
active ingredient in antibacterial drug is a derivative of nitrofuran - nifuratel.Auxiliary components - starch, talc, polyethylene glycol 6000, sucrose, magnesium carbonate, and others.In a joint application with the active substance Nystatin "Makmiror" can greatly enhance the antifungal activity of the drug.
pharmacological action of the drug
«Makmiror" is a tool widely used, which has an active antibacterial, antiprotozoal and antifungal effects.The main ingredient of the drug is very effective and virtually non-toxic, which explains its frequent use in the treatment of infectious diseases.
Assignment "Makmiror" occurs in the cas
After providing a strong antibacterial effect of the drug is completely eliminated from the body by the kidneys.
permissible dosage "Makmiror»
If urinary tract infections adults drug is given 3-6 tablets (200 mg each nifuratel) per night.Babies dose is reduced to 30-60 milligrams per one kilogram of body weight per day and given.Recommended time of reception - 1-2 weeks, but in the case of the corresponding destination physician, the drug may be repeated.
If necessary, the treatment of vaginal infections adults should take 1 tablet 3 times in one day for a total course length of 7 days.And when the children's problems, as described in the summary "Makmiror" has 10 milligrams of the drug per kilogram of weight in 2 hours per day, but for the past 10 days.
Side effects during pregnancy and the use of
In rare cases, the patient may appear negative reaction on the part of the digestive system - nausea, repeated vomiting, bitter taste in the mouth, diarrhea, medium strength, heartburn and gastralgia.
possible and the emergence of allergic complications - skin rash and itching.
If necessary, use "Makmiror" in pregnancy the patient must be sure to consult your doctor and the appointment, as the active ingredient of the drug may endanger the unborn child.
At the beginning of breastfeeding medicine is not appointed as the practice of using shows that nifuratel excreted in breast milk of women, and is transmitted to the child.